LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 49 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,414,468 | $8,720,383 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $53,026,447 | 1.13% |
| Opaleye Management Inc. | 1,390,000 | $4,350,700 | 1.04% |
| DAFNA Capital Management LLC | 350,373 | $1,096,667 | 0.30% |
| MANGROVE PARTNERS IM, LLC | 805,815 | $2,522,201 | 0.18% |
| Atlas Venture Advisors, Inc. | 292,184 | $914,536 | 0.16% |
| Verition Fund Management LLC | 2,716,713 | $8,503,312 | 0.11% |
| Woodline Partners LP | 1,681,913 | $5,264,388 | 0.06% |
| Fi3 FINANCIAL ADVISORS, LLC | 25,548 | $79,965 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 363,505 | $1,137,771 | 0.04% |